Better Buy: Illumina vs. Guardant Health
In recent years, investors have been drawn to healthcare companies focused on genetic research. This field has transformed science and medicine, and its innovations have made some investors wealthy from its successes.
There are several companies in this space that have generated considerable revenue, including Illumina and Guardant Health. Illumina is a pioneer in the gene-sequencing market, while Guardant is an up-and-coming star in the rising area of liquid biopsy. Which of these healthcare stocks is a better buy for the long run?
Image source: Getty Images.
Source Fool.com
